id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-034371-j3xxmkjd	Schellack, Natalie	COVID-19: Guidelines for pharmacists in South Africa	2020-06-10		.txt	text/plain	5039	344	54	This evidence-based review is aimed at providing guidance for pharmacists in community, hospital and other settings in South Africa, on the management of patients with suspected or confirmed coronavirus disease 2019, or COVID-19. • Epidemiology • The virus, its modes of transmission and incubation period • Symptom identification, including the differentiation between influenza, allergic rhinitis, sinusitis and COVID-19 • Social media myths and misinformation • Treatment guidelines and medicines that may need to be kept in stock • Treatment and prevention options, including an update on vaccine development • The case for and against the use of NSAIDs, ACE-inhibitors and angiotensin receptor blockers (ARBs) in patients with COVID-19 • Interventions and patient counselling by the pharmacist. The current NDoH/NICD guidelines do not recommend the use of chloroquine (CQ)/ hydroxychloroquine (HCQ), due to insufficient evidence, in the treatment of patients with suspected or confirmed COVID-19.	./cache/cord-034371-j3xxmkjd.txt	./txt/cord-034371-j3xxmkjd.txt